We believe a comprehensive, data and technology driven approach to care will significantly increase the odds of permanent addiction recovery.
About entheonInvestor RelationsPlease enter your information to receive our investor package or reach out to us directly using the information below.
Joseph Cullen
Investor Relations
ir@entheonbiomedical.com
+1 (778) 919-8615